Hear from the Experts: Stem Cell Research & Treatment in MS (Oct. 3, 2023)
239
Published 2023-11-22
All Comments (2)
-
I was that patient who should have had HSCT first. Unfortunately I was put on copaxone for 1.5 years, then gylenya for 1.5 years then 2 rounds of Lemtrada. None of which helped. If I had been given HSCT when I was diagnosed at the age of 40 in 2014 my outcome would likely have been different. At that time I could still walk and but had aggressive MS with active disease. By mid 2017 and at the start of my first Lemtrada infusion I could barely walk on my own. By 2018 I was in a scooter full time.
